Shah, PI et al
"Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatment." European Respiratory Journal
8.6
(1995):
954-958.
Web. 18 April. 2024.